PDF Publication Title:
Text from PDF Page: 001
Received: 2020.06.12 Accepted: 2020.07.31 Available online: 2020.08.07 Published: 2020.XX.XX ABCDEF 1 ABCDEF 2 A3 BCDEF 4 Corresponding Author: Conflict of interest: Patient: Final Diagnosis: Symptoms: Medication: Clinical Procedure: Specialty: Objective: Background: Case Report: Conclusions: MeSH Keywords: Full-text PDF: e-ISSN 1941-5923 © Am J Case Rep, 2020; 21: e926779 DOI: 10.12659/AJCR.926779 A 57-Year-Old African American Man with Severe COVID-19 Pneumonia Who Responded to Supportive Photobiomodulation Therapy (PBMT): First Use of PBMT in COVID-19 Scott A. Sigman Soheila Mokmeli Monica Monici Mariana A. Vetrici Scott A. Sigman, e-mail: sasigmanmd@icloud.com None declared Male, 57-year-old COVID-19 Shortness of breath • hypoxia — Photobiomodulation therapy (PBMT) Infectious Diseases • Pulmonology Unusual or unexpected effect of treatment Coronavirus disease 2019 (COVID-19) is associated with lung inflammation and cytokine storm. Photobiomodulation therapy (PBMT) is a safe, non-invasive therapy with significant anti-inflammatory effects. Adjunct PBMT has been employed in treating patients with lung conditions. Human studies and experimental models of respira- tory disease suggest PBMT reduces inflammation and promotes lung healing. This is the first time supportive PBMT was used in a severe case of COVID-19 pneumonia. A 57-year-old African American man with severe COVID-19 received 4 once-daily PBMT sessions by a laser scan- ner with pulsed 808 nm and super-pulsed 905 nm modes for 28 min. The patient was evaluated before and after treatment via radiological assessment of lung edema (RALE) by CXR, pulmonary severity indices, blood tests, oxygen requirements, and patient questionnaires. Oxygen saturation (SpO2) increased from 93–94% to 97–100%, while the oxygen requirement decreased from 2–4 L/min to 1 L/min. The RALE score improved from 8 to 5. The Pneumonia Severity Index improved from Class V (142) to Class II (67). Additional pulmonary indi- ces (Brescia-COVID and SMART-COP) both decreased from 4 to 0. CRP normalized from 15.1 to 1.23. The pa- tient reported substantial improvement in the Community-Acquired Pneumonia assessment tool. This report has presented supportive PBMT in a patient with severe COVID-19 pneumonia. Respiratory indi- ces, radiological findings, oxygen requirements, and patient outcomes improved over several days and with- out need for a ventilator. Future controlled clinical trials are required to evaluate the effects of PBMT on clini- cal outcomes in patients with COVID-19 pneumonia. Anti-Inflammatory Agents • COVID-19 • Laser Therapy • Respiratory Distress Syndrome, Adult https://www.amjcaserep.com/abstract/index/idArt/926779 Authors’ Contribution: Study Design A Data Collection B Statistical Analysis C Data Interpretation D Manuscript Preparation E Literature Search F Funds Collection G 2353 2 3 35 1 Team Physician, UMASS Lowell, Fellow of the World Society of Sports and Exercise Medicine, Fellow of the Royal College of Surgeons in Ireland, Chelmsford, MA, U.S.A. 2 Training Institute, Canadian Optic and Laser Center, Victoria, BC, Canada 3 Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy 4 Department of Biological Sciences, University of Lethbridge, Lethbridge, AB, Canada This work is licensed under Creative Common Attribution- NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) 1 Indexed in: [PMC] [PubMed] [Emerging Sources Citation Index (ESCI)] [Web of Science by Clarivate] APPROVED GALLEY PROOFPDF Image | A COVID-19 Pneumonia Responded to Photobiomodulation Therapy
PDF Search Title:
A COVID-19 Pneumonia Responded to Photobiomodulation TherapyOriginal File Name Searched:
laser-therapy-severe-COVID-19-case.pdfDIY PDF Search: Google It | Yahoo | Bing
Cruise Ship Reviews | Luxury Resort | Jet | Yacht | and Travel Tech More Info
Cruising Review Topics and Articles More Info
Software based on Filemaker for the travel industry More Info
The Burgenstock Resort: Reviews on CruisingReview website... More Info
Resort Reviews: World Class resorts... More Info
The Riffelalp Resort: Reviews on CruisingReview website... More Info
| CONTACT TEL: 608-238-6001 Email: greg@cruisingreview.com | RSS | AMP |